Business Wire
16 Aug 2026, 21:38 UTC · 10w ago
TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law
Impact · against what's priced in
Tenax Therapeutics faces significant downside risk following the announcement of a fraud investigation by SBS Law. As a new material development, this creates immediate uncertainty regarding corporate governance and potential regulatory penalties.
- TENX−0.80
No priced-in read yet





